A Randomized, Controlled, Clinical Trial of Biofeedback and Anal Injections as First Treatment of Fecal Incontinence
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
A short presentation of a randomized clinical trial of biofeedback and anal injections as a first treatment option of faecal incontinence.
Background: Faecal incontinence affects mainly women who have suffered sphincter disruption from vaginal delivery, but individuals of all ages can be affected. The treatment of this debility is not uniform between institutions or internationally. Often is surgical reconstruction of the anal sphincter performed, or other invasive, costly treatment options.
The study: We intend to conduct a randomized, controlled, clinical trial where we compare the effect of two less invasive, less costly treatment options as a first alternative: biofeedback and anal injections. Our hypothesis is that anal injections will give a better and more lasting effect than biofeedback. The primary endpoint will be change in faecal incontinence assessed by the St. Marks incontinence score. Secondary endpoints will include change in quality of life and several physiological parameters. We intend to include 62 patients in both groups, 124 all together, from 2 centres in Norway. The observation time is 2 years. We plan to include the first patient April 2006, and conclude the study by December 2010. This study can contribute to a more appropriate treatment-algorithm for these patients.
Study group:
- Barthold Vonen MD PhD, Department of gastroenterological surgery, University Hospital of North Norway
- Rolv-Ole Lindsetmo MD PhD, Department of gastroenterological surgery, University Hospital of North Norway
- Arvid Stordahl MD PhD., Department of Surgery, Østfold Hospital Fredrikstad
- Ylva Sahlin MD PhD, Department of Surgery, Innlandet Hospital Hamar
- Trond Dehli, MD, Department of gastroenterological surgery, University Hospital of North Norway
- Kjersti Mevik, Stud. Med, University of Tromso
Project manager: Trond Dehli
Funding, approvals, publication: This study is funded from Northern Norway Regional Health Authority and The Institution of Norwegian Health- and rehabilitation-organizations. It has been approved by the Regional Committee for Medical Research Ethics and Norwegian Social Science Data Services. The results will be published in an international peer-reviewed journal after the Vancouver-convention's guidelines. The results will also be presented at national and international conferences.
Contact:
Trond Dehli, Department of gastroenterological surgery, University hospital North Norway, Breivika, 9038 Tromsø trond.dehli@unn.no tlf: +47 776 26 000
| Condition | Intervention | Phase |
|---|---|---|
|
Fecal Incontinence |
Procedure: 1. Anal injection Procedure: 2. Biofeedback |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | A Randomized, Controlled, Clinical Trial of Biofeedback and Anal Injections as First Treatment of Fecal Incontinence. |
- Incontinence measured by St.Marks incontinence score [ Time Frame: 2 years ] [ Designated as safety issue: No ]
- Health related Quality of Life measures [ Time Frame: 2 years ] [ Designated as safety issue: No ]
- Physiologic measures [ Time Frame: 2 years ] [ Designated as safety issue: No ]
| Enrollment: | 126 |
| Study Start Date: | May 2006 |
| Study Completion Date: | June 2011 |
| Primary Completion Date: | June 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Active Comparator: 1. Anal injection |
Procedure: 1. Anal injection
Submucosal injection just above the linea dentata in the anal canal of 4 x 1 ml of dextranomere.
Other Name: Solesta
|
| Active Comparator: 2. Biofeedback |
Procedure: 2. Biofeedback
Training under the guidance of a physiotherapist with the help of a biofeedback device with an anal probe.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Fecal incontinence lasting more than 6 months
- St. Marks score of 4 or more
- No known local or general neurological disease
- 18 years or older
- No constipation
Exclusion Criteria:
- Total rupture of the sphincter of more than 120 degrees
- Diabetes mellitus with late complications (neurological og cardiovascular)
- Ulcus simplex/rectal ulcus
- Anal/rectal prolapse
- ileo-anal anastomosis
- Cancer recti or cancer ani last 2 years
- Pregnancy
Contacts and Locations| Norway | |
| Innlandssykehuset Hamar | |
| Hamar, Norway | |
| Anorektallaboratoriet, Østfoldsykehuset Sarpsborg | |
| Sarpsborg, Norway, 1723 | |
| Avdeling for gastroenterologisk kirurgi, University hospital of North Norway | |
| Tromso, Norway, 9016 | |
| Study Director: | Barthold Vonen, M.D., Ph.D. | University of Tromsø, Norway |
More Information
No publications provided
| Responsible Party: | University Hospital of North Norway |
| ClinicalTrials.gov Identifier: | NCT00303030 History of Changes |
| Other Study ID Numbers: | Biofeedback or injections |
| Study First Received: | March 14, 2006 |
| Last Updated: | November 16, 2011 |
| Health Authority: | Norway: Norwegian Social Science Data Services |
Keywords provided by University Hospital of North Norway:
|
Fecal incontinence Biofeedback Patient Satisfaction Quality of LifeTreatment Outcome Injections |
Additional relevant MeSH terms:
|
Fecal Incontinence Rectal Diseases Intestinal Diseases Gastrointestinal Diseases Digestive System Diseases |
ClinicalTrials.gov processed this record on May 23, 2013